These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16107890)

  • 1. Reply to Gaipa et Al.
    van der Sluijs-Gelling AJ; van der Velden VH; Roeffen ET; Veerman AJ; van Wering ER
    Leukemia; 2005 Oct; 19(10):1858. PubMed ID: 16107890
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death.
    van der Sluijs-Gelling AJ; van der Velden VH; Roeffen ET; Veerman AJ; van Wering ER
    Leukemia; 2005 Oct; 19(10):1845-7. PubMed ID: 16107891
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
    Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
    Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia.
    Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunophenotyping of acute lymphoblastic leukemia in Mexican children].
    Paredes-Aguilera R; Romero-Guzmán L; López-Santiago N; Bravo-Lindoro A; Correa-González C; Joly-Linero R; Nieto-Martínez S; del Campo-Martínez A
    Sangre (Barc); 1999 Jun; 44(3):188-94. PubMed ID: 10481579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A T-lineage neoplasm-Which one?
    Bain BJ; Fawcett N
    Am J Hematol; 2009 Oct; 84(10):678. PubMed ID: 19373891
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phenotypic changes in refractory and relapse acute lymphoblastic leukemias].
    Gómez E; San Miguel JF; González M; Orfao A; Cañizo MC; Ciudad J; López Borrasca A
    Sangre (Barc); 1991 Jun; 36(3):201-4. PubMed ID: 1948539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
    Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
    J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
    Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
    Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The morphological and immunological classification of acute leukemias].
    Jansson SE
    Duodecim; 1989; 105(11):973-86. PubMed ID: 2666098
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and phenotypic heterogeneity in L3-acute lymphoblastic leukaemia.
    Advani SH; Ahuja HG; Gopal R; Athanikar N; Nair CN; Saikia T; Nadkarni KS; Kumar A
    Indian J Cancer; 1988 Jun; 25(2):108-13. PubMed ID: 3263938
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal development of the acute leukemias.
    Fialkow PJ; Raskind WR; Singer JW; Dow LW; Najfeld V; Veith R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():76-8. PubMed ID: 2653523
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic natural killer-cell lymphoma: a case report.
    Wilentz SE
    Cutis; 2006 Jan; 77(1):42-4. PubMed ID: 16475495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis of hematolymphoid malignancies in childhood].
    Li GD
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):765-8. PubMed ID: 16545180
    [No Abstract]   [Full Text] [Related]  

  • 18. Linking the hematopoietic microenvironment to imatinib-resistant Ph+ B-ALL.
    Dorshkind K; Witte ON
    Genes Dev; 2007 Sep; 21(18):2249-52. PubMed ID: 17875661
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphoblastic lymphoma (LBL) and acute lymphoblastic leukaemia (ALL) in adults: relationships and therapeutic perspectives.
    Santini G; Congiu A; D'Amico T; Gaozza E; Occhini D; Carlier P; Nati S; Pungolino E; Marmont AM
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():106-7. PubMed ID: 2653482
    [No Abstract]   [Full Text] [Related]  

  • 20. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
    Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
    Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.